Castle Biosciences, Inc. (CSTL)
USD 26.52
(-5.76%)
USD 26.52
(-5.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -57.46 Million USD | 14.41% |
| 2022 | -67.13 Million USD | -114.55% |
| 2021 | -31.29 Million USD | -204.28% |
| 2020 | -10.28 Million USD | -294.88% |
| 2019 | 5.27 Million USD | 182.88% |
| 2018 | -6.36 Million USD | 48.53% |
| 2017 | -12.36 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 2.26 Million USD | -74.56% |
| 2024 Q2 | 8.92 Million USD | 452.01% |
| 2024 Q1 | -2.53 Million USD | 1.78% |
| 2023 Q2 | -18.77 Million USD | 35.7% |
| 2023 Q1 | -29.2 Million USD | -41.64% |
| 2023 FY | -57.46 Million USD | 14.41% |
| 2023 Q4 | -2.58 Million USD | 62.64% |
| 2023 Q3 | -6.9 Million USD | 63.23% |
| 2022 Q3 | -18.81 Million USD | -1041.44% |
| 2022 Q2 | -1.64 Million USD | 93.31% |
| 2022 Q1 | -24.62 Million USD | -282.94% |
| 2022 FY | -67.13 Million USD | -114.55% |
| 2022 Q4 | -20.61 Million USD | -9.61% |
| 2021 Q1 | -4.28 Million USD | 12.46% |
| 2021 Q2 | -8.79 Million USD | -105.4% |
| 2021 Q3 | -11.79 Million USD | -34.13% |
| 2021 FY | -31.29 Million USD | -204.28% |
| 2021 Q4 | -6.43 Million USD | 45.47% |
| 2020 FY | -10.28 Million USD | -294.88% |
| 2020 Q2 | -1.37 Million USD | -341.4% |
| 2020 Q1 | 570 Thousand USD | -72.26% |
| 2020 Q4 | -4.88 Million USD | -6.54% |
| 2020 Q3 | -4.58 Million USD | -233.5% |
| 2019 Q1 | -1.35 Million USD | -135.1% |
| 2019 Q4 | 2.05 Million USD | -64.87% |
| 2019 FY | 5.27 Million USD | 182.88% |
| 2019 Q3 | 5.84 Million USD | 560.91% |
| 2019 Q2 | -1.26 Million USD | 6.55% |
| 2018 Q2 | -3.15 Million USD | 13.1% |
| 2018 Q4 | 3.86 Million USD | 212.13% |
| 2018 Q1 | -3.63 Million USD | 0.0% |
| 2018 FY | -6.36 Million USD | 48.53% |
| 2018 Q3 | -3.45 Million USD | -9.35% |
| 2017 FY | -12.36 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 75.283% |
| Prenetics Global Limited | -62.72 Million USD | 8.383% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3612.274% |
| CareDx, Inc | -190.28 Million USD | 69.8% |
| Exact Sciences Corporation | -204.14 Million USD | 71.851% |
| Exagen Inc. | -23.68 Million USD | -142.585% |
| Inotiv, Inc. | -105.14 Million USD | 45.343% |
| Guardant Health, Inc. | -479.44 Million USD | 88.014% |
| Biodesix, Inc. | -52.14 Million USD | -10.202% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -2085.814% |
| Precipio, Inc. | -5.85 Million USD | -881.821% |
| iSpecimen Inc. | -11.09 Million USD | -417.736% |
| Natera, Inc. | -434.8 Million USD | 86.783% |
| Aspira Women's Health Inc. | -16.69 Million USD | -244.314% |
| Standard BioTools Inc. | -74.65 Million USD | 23.026% |
| 23andMe Holding Co. | -666.7 Million USD | 91.381% |
| Personalis, Inc. | -108.29 Million USD | 46.936% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 35.053% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -477.718% |
| OpGen, Inc. | -32.66 Million USD | -75.906% |
| T2 Biosystems, Inc. | -50.07 Million USD | -14.755% |
| Myriad Genetics, Inc. | -112 Million USD | 48.691% |
| ICON Public Limited Company | 612.33 Million USD | 109.385% |
| NeoGenomics, Inc. | -87.96 Million USD | 34.674% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3612.274% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 106.8% |
| RadNet, Inc. | 3.04 Million USD | 1987.845% |
| MDxHealth SA | -43.1 Million USD | -33.332% |
| Psychemedics Corporation | -4.15 Million USD | -1283.39% |
| Illumina, Inc. | -1.16 Billion USD | 95.05% |
| Check-Cap Ltd. | -17.56 Million USD | -227.106% |
| Twist Bioscience Corporation | -208.72 Million USD | 72.468% |
| DarioHealth Corp. | -59.42 Million USD | 3.3% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 65.758% |
| Sera Prognostics, Inc. | -36.24 Million USD | -58.562% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -471.218% |
| OPKO Health, Inc. | -188.86 Million USD | 69.573% |
| Medpace Holdings, Inc. | 282.81 Million USD | 120.32% |
| Neogen Corporation | -9.42 Million USD | -509.978% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -465.791% |
| Prenetics Global Limited | -62.72 Million USD | 8.383% |
| Mainz Biomed B.V. | -26.29 Million USD | -118.537% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -624.026% |
| Trinity Biotech plc | -24.01 Million USD | -139.262% |
| Neuronetics, Inc. | -30.18 Million USD | -90.354% |
| Sotera Health Company | 51.37 Million USD | 211.854% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -624.026% |